SCHEMBL6409289

SCHEMBL6409289

COC(=O)NC(CCN1CCC2(CC1)CCN(Cc1ccc(Br)cc1)C2=O)c1cccc(OC)c1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 2/20 0.45
ROCK1 Q13464 2/20 0.45
MMP1 P03956 2/20 0.39
MMP9 P14780 2/20 0.39
MMP13 P45452 2/20 0.39
ADAM17 P78536 2/20 0.39
CACNA1G O43497 1/20 0.39
CXCR3 P49682 1/20 0.39
LMNA P02545 3/20 0.38
HDAC11 Q96DB2 1/20 0.38
THRB P10828 1/20 0.38
RECQL P46063 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CCR5 P51681 2/20 0.38
HTT P42858 1/20 0.37
DRD2 P14416 1/20 0.37
DRD4 P21917 1/20 0.37
OPRM1 P35372 1/20 0.37
DRD3 P35462 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6409286 0.99 ROCK2 (0.44) ROCK2ROCK1MMP1MMP9MMP13
SCHEMBL6409742 0.94 ROCK2 (0.47) ROCK2ROCK1MMP1MMP9MMP13
SCHEMBL6410226 0.94 ROCK2 (0.43) ROCK2ROCK1MMP1MMP9MMP13
Hydrochloric Acid SCHEMBL6409741 0.93 ROCK2 (0.46) ROCK2ROCK1MMP1MMP9MMP13
Hydrochloric Acid SCHEMBL6410218 0.93 ROCK2 (0.42) ROCK2ROCK1MMP1MMP9MMP13
SCHEMBL6408718 0.93 ROCK2 (0.42) ROCK2ROCK1MMP1MMP9MMP13
SCHEMBL6417273 0.93 HDAC11 (0.37) ROCK2ROCK1LMNAHDAC11SMN1; SMN2
Hydrochloric Acid SCHEMBL6417268 0.92 HDAC11 (0.37) ROCK2ROCK1LMNAHDAC11SMN1; SMN2
SCHEMBL6412179 0.92 MMP1 (0.44) MMP1MMP9MMP13ADAM17CACNA1G
Hydrochloric Acid SCHEMBL6412173 0.91 MMP1 (0.43) MMP1MMP9MMP13ADAM17CACNA1G

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050075326-A1 Spiro compounds and methods for the modulation of chemokine receptor activity VIROCHEM PHARMA INC (CA) 2005-04-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050075326-A1 Spiro compounds and methods for the modulation of chemokine receptor activity CXCR1, CXCR4, CXCR2 ROCK2 1735/4885ROCK1 1002/4885MMP1 873/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.